KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Interest & Investment Income (2016 - 2018)

Medtronic's Interest & Investment Income history spans 4 years, with the latest figure at $650.0 million for Q2 2018.

  • For Q2 2018, Interest & Investment Income fell 27.62% year-over-year to $650.0 million; the TTM value through Apr 2018 reached $397.0 million, down 36.98%, while the annual FY2018 figure was $397.0 million, 8.47% up from the prior year.
  • Interest & Investment Income for Q2 2018 was $650.0 million at Medtronic, up from -$172.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $898.0 million in Q2 2017 and bottomed at -$180.0 million in Q1 2017.
  • The 4-year median for Interest & Investment Income is $92.0 million (2017), against an average of $122.3 million.
  • The largest YoY upside for Interest & Investment Income was 716.36% in 2017 against a maximum downside of 290.11% in 2017.
  • A 4-year view of Interest & Investment Income shows it stood at $113.0 million in 2015, then dropped by 19.47% to $91.0 million in 2016, then crashed by 290.11% to -$173.0 million in 2017, then soared by 475.72% to $650.0 million in 2018.
  • Per Business Quant, the three most recent readings for MDT's Interest & Investment Income are $650.0 million (Q2 2018), -$172.0 million (Q1 2018), and -$173.0 million (Q4 2017).